Purpose: Giant papillary conjunctivitis in patients wearing contact lenses occurs after intolerance and/or allergy to contact lenses. Eotaxin is a CC chemokine with a potent and specific chemotactic effect for eosinophils, which are involved in allergies. The purpose of this study is to measure the eotaxin levels in tears of patients wearing contact lenses and in normal subjects. Eotaxin levels were also correlated with the grade of giant papillary conjunctivitis.
G iant papillae can be observed in vernal keratoconjunctivitis, atopic keratoconjunctivitis, and giant papillary conjunctivitis. Giant papillae present a flat top and are polygonal in shape. They are frequently associated with conjunctival edema, which is responsible for a milky color. The pathogenic mechanism in giant papillary conjunctivitis has been ascribed to the combined effect of mechanical trauma followed by repeat immunologic presentation of foreign antigens in the form of surface deposits or environmental agents. 1, 2 When giant papillary conjunctivitis is related to contact lens (CL) wear, the term contact lens papillary conjunctivitis (CLPC) is frequently used. Studies analyzing tear samples from patients with giant papillary conjunctivitis have shown increased levels of IgE and in some cases IgG and IgM. 1 Protein deposits on the surface of the contact lens could be a major factor in the development of CLPC. 3 In soft contact lens wearers, lens-induced papillary conjunctivitis may develop after 3 weeks or take as long as 4 years to manifest. In rigid contact lens wearers, CLPC typically appears after a mean time of 14 months. 4 Because immunoglobulins are increased in tears of patients with giant papillary conjunctivitis, 1 cytokines and chemokines are probably involved in this process. CC chemokines such as eotaxin 5, 6 and RANTES 7 are involved in the recruitment of eosinophils. Eotaxin has a potent and selective chemotactic effect for eosinophils. Three isoforms have been isolated, which are functionally similar. All 3 are known to interact through the CC chemokine receptor 3 (CCR3), 8 which is mainly expressed on eosinophils, 9 basophils, 10 and Th2 cells, 11 whose expression is reported to increase during allergic reactions.
The purpose of this study is first to determine the eotaxin-1 levels in patients with CLPC and in normal subjects, and second to determine if a correlation between eotaxin levels and the degree of CLPC present.
MATERIALS AND METHODS
Sixteen patients (16 eyes) wearing contact lenses were included in our study (Table 1) . Four were male, and 12 female. The mean age was 28.6 (SEM 5.1) years (range 17-39 years). No subjective symptoms, such as itching, redness, photophobia, or tearing, were mentioned by the patients. Control subjects were 10 volunteers (10 eyes), ophthalmologically normal with no ocular or systemic symptoms. One was male, and 9 female. The mean age was 40.9 (SEM 9.6) years (range 29-55 years). Each individual included in our study underwent a complete ophthalmic examination. Conjunctival papilla grade was always performed in a blind manner by the same ophthalmologist. The degree of CLPC of our patients was obtained by slit-lamp examination and scored from 0 to 4 accord-ing to standard photos of a universally accepted concept that denotes increasing clinical severity as the numeric grade increases ( Table 2 and Fig. 1 ). 12 Patients or controls with history of allergy were excluded from our study.
All the experiments in this study followed the tenets of Declaration of Helsinki. After informed consent was obtained, around 10 µL of tear samples were collected over a period of 5 minutes from all patients wearing contact lenses or control subjects. To obtain unstimulated basal tears, the tear samples were collected with microcapillary tubes at the lateral canthus of the eyelid in supine patients with heads tilted to the side. No anesthetic was used. Tear samples were centrifuged immediately at 4°C to remove cells and transferred to new tubes. Tear samples were immediately frozen at −70°C until further analysis.
Eotaxin concentrations in tears were measured by a modified enzyme-linked immunosorbent assay (ELISA). An ELISA plate is coated with a capture antibody, the purified mouse anti-human eotaxin monoclonal antibody 3C7 (Becton Dickinson-Pharmingen, #23051D) at the appropriate concentration in binding solution (phosphate buffer, pH 9). A serial dilution of recombinant human eotaxin between 16 and 500 pg/mL and dilutions of samples are prepared in 0.05% Tween and 1% BSA in PBS (Tween/BSA/PBS). After washing and blocking of nonspecific binding, recombinant eotaxin dilutions in duplicate and samples are added. The plate is washed, and a detecting antibody, the biotinylated mouse anti-human eotaxin monoclonal antibody 10C11 (Becton Dickinson-Pharmingen, #23252D) is added at the appropriate concentration in Tween/BSA/PBS. The plate is washed, and streptavidin-alkaline phosphatase conjugate (BD-Pharmingen #554065) is added. Associated detection method is applied, and the OD is read at 405 nm. Eotaxin concentration in the samples is determined from the standard curve of eotaxin. The limit of the sensitivity of the test was 60 pg/mL of eotaxin.
Statistical analysis was performed by using the Wilcoxon/Kruskal-Wallis test, and 1-way analysis of variance (ANOVA) was used to analyze the statistical significance of differences between eotaxin levels in tear samples of patients wearing contact lenses and normal individuals. P < 0.05 was considered to indicate significance.
RESULTS
Analysis of tears from the contact lens group shows that the mean eotaxin concentration is equal to 2698 ± 233 pg/mL (mean ± SEM) with a range of 1571-4194 pg/mL (Fig. 2) . Analysis of tears from the control group reveals a mean eotaxin concentration equal to 1498 ± 139 pg/mL (mean ± SEM), with a range of 611-2126 pg/mL. Statistical analysis was performed using the Wilcoxon/Kruskal-Wallis test, which shows that the eotaxin concentration in tears from the contact lens group was significantly greater than that in the control group (P = 0.0004) ( Table 3 , Fig. 2) .
To further explain the increase of eotaxin in tears of the contact lens group, we examined the papilla grade of our study group. The degree of papilla grade of our patients was obtained by slit-lamp examination of the upper tarsal conjunctiva and scored from 0 to 4 according to standard photos of a universally accepted concept. The mean papilla grade of the contact lens group is equal to 1.75 ± 0.19 (mean ± SEM) with a range of 0-3. The mean papilla grade of the control group is equal to 0.2 ± 0.13 (mean ± SEM) with a range of 0-1. The Wilcoxon/Kruskal-Wallis test shows that the papilla grade in the contact lens group was significantly greater than that from the control group (P < 0.0001) ( Table 3 , Fig. 3) .
Moreover, the contact lens group and the control group were pooled to see if a correlation between the eotaxin concentration in tears and the papilla grade is observed. Statistical analysis was performed using bivariate analysis (Fig. 4) . The coefficient of determination or R 2 is equal to 0.6562 with a P < 0.0001. This means that there is a correlation between eotaxin concentration in tears and papilla grade.
DISCUSSION
Eotaxin, a potent CC chemokine originally purified from the bronchoalveolar lavage fluid from allergen-challenged guinea pigs, is a potent and selective eosinophil chemoattractant. 13 In addition, eotaxin is a potent activator of the respiratory burst and actin polymerization of eosinophils. 14 Eotaxin, therefore, plays an important role not only by attracting eosinophils to the site of inflammation but also by damaging tissue through its capacity to induce the release of reactive oxygen species. 15 In conjunctival biopsies from normal individuals, there was a constitutive, weak expression of eotaxin immunoreactivity in the epithelial layer. 16 Compared with nor- Cornea • Volume 23, Number 8, November 2004 Eotaxin in Tears mal conjunctivae, the conjunctivae from patients with vernal keratoconjunctivitis showed a strong expression of eotaxin in the epithelial layer, stromal inflammatory cells, and vascular endothelial cells. 16 Eotaxin-1 is produced by various cell types including lung/bronchial epithelial cells, fibroblasts, smooth muscle cells, and eosinophils themselves. 17 It has recently been demonstrated that conjunctival epithelial cells are capable of synthesizing eotaxin. 18 It is also reported that eotaxin is present in tears of allergic patients with severe corneal damage, correlating with the number of eosinophils in tears. 19 We hypothesized that in patients wearing contact lenses, local antigenic factors can trigger eotaxin production, which acts as a chemotactic factor for eosinophils. 20 Once eosinophils are activated, they release toxic mediators, and the whole local inflammatory response induces the papilla formation. 21 In our study, patients wearing contact lenses did not mention subjective symptoms, such as itching, photophobia, or tearing. It is known that such patients remain asymptomatic at the beginning, despite developing a certain degree of giant papillary conjunctivitis. Moreover, our patients showed a mild to moderate grade of papilla, but none of them showed a severe papilla grade (grade 4). Finally, patients wearing lenses are found to be much more tolerant to foreign bodies than normal subjects.
We successfully detected high concentrations of eotaxin and relatively high papilla grade in tear samples from patients wearing contact lenses. A clear correlation was also observed between eotaxin level in tears and papilla grade. This correlation indicates that either one parameter influences the other or both parameters depend on a third one.
A recent study could not show an increase of eotaxin level in tears of patients wearing a prosthesis and presenting a giant papillary conjunctivitis compared with healthy controls. 2 The authors explain the absence of eotaxin in such patients by the lack of corneal involvement. 2 It is known that tears of patients wearing prostheses have a different composition compared with normal subjects, namely, a decrease in aqueous phase and an increase in mucous secretion. 1, 22 We would suggest that, in patients wearing prostheses, eotaxin production could be reduced because of the lack of some ocular tissues. It may also be that some components of the tears of patients wearing prostheses, up from a certain concentration, may interfere with eotaxin protein.
Our data suggest that eotaxin may play an important role in papilla formation by the following mechanism: Eotaxin has a potent and selective chemotactic effect for eosinophils by binding to the receptor CCR3, whose expression is reported to increase during allergic reactions. 5, 6, 8 Once the eosinophils increase, they are found in the epithelium and in the stroma of the conjunctiva with other inflammatory cells. This whole redistribution of inflammatory cells between the epithelium and the stroma of the conjunctiva causes pathologic structural changes, which characterize the papilla formation and consequently the CLPC.
In conclusion, the expression of eotaxin-1 may in part be responsible for the conjunctival accumulation of eosinophils and other inflammatory cells observed in the CLPC. Eotaxin is an important mediator involved in ocular surface disease of allergic origin. However, further studies are required to establish the exact role of eotaxin on the ocular surface, the complex crosstalk of inflammatory mediators, and the specific therapeutic approach needed for the CLPC. 
